As one of the largest and fastest growing segments of the worldwide medical device market, neuromodulation devices are poised to more than double in revenues over the next decade. Although advances in spinal cord stimulation (SCS) will help drive much of the near-term growth in this market (see Also see "Neuromodulation Market: Innovation Brings High-Growth Rewards" - Medtech Insight, 27 March, 2013.), emerging technologies in peripheral nerve stimulation (PNS) will play a pivotal role in opening up new applications and driving double-digit growth in neuromodulation for many years to come. The neuromodulation pipeline is rich with products designed to address a growing number of patients with long-term pain and other chronic conditions, many of whom have no other treatment options. These emerging devices are taking aim at some large and highly unpenetrated markets desperate for new, more effective therapies to treat a variety of complex conditions including heart failure, chronic low back pain, obstructive sleep apnea, chronic postsurgical pain, chronic migraine, shoulder pain, postamputation pain, postoperative knee pain, rheumatoid arthritis, Crohn’s disease, and trigeminal neuralgia, among others.
In the paragraphs that follow, we profile several emerging competitors developing innovative new technologies in the peripheral nerve stimulation space – all with the
